Predictive relevance of HOXB13 protein expression for tamoxifen benefit in breast cancer

INTRODUCTION: The HOXB13:IL17BR index has been identified to predict clinical outcome in the setting of adjuvant tamoxifen monotherapy of breast cancer. Further studies have shown that HOXB13 in particular can indicate benefit of prolonged tamoxifen treatment. Patients with high-expressing tumors di...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Jerevall, Piiha-Lotta, Jansson, Agneta, Fornander, Tommy, Skoog, Lambert, Nordenskjöld, Bo, Stål, Olle
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2010
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2949642/
https://ncbi.nlm.nih.gov/pubmed/20649975
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr2612
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items